Efficacy of the Speech Intelligibility Index as an intervention tool with pediatric cancer patients

This study evaluates the Speech Intelligibility Index (SII) as a tool to describe hearing loss and predict when hearing aids would be appropriate for pediatric oncology patients who have received or are currently receiving cisplatin. The efficacy of the SII is compared to the Brock grade which is commonly used for patients with ototoxic hearing loss secondary to cisplatin treatment. The SII is a discrete measure that precisely reflects the patient’s functional hearing status and is highly correlated with the need for audiologic intervention.

Validating the Mainstream Success Index

This paper seeks to evaluate and validate the efficiency of the Mainstream Success Index.

Correlation of the articulation index to the MTS test under different listening conditions

This paper reviews a study to determine the relation between the aided articulation index and the aided speech recognition scores obtained with the Monosyllable, Trochee and Spondee (MTS) Test, when administered to hearing-impaired children.